Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glywin 30mg Tablet MR

Prescription Icon
Prescription Required

Marketer

Bison Biotec Pvt Ltd

Salt Composition

Gliclazide (30mg)

Overview Glywin 30mg Tablet MR

Diabetic patients (adults) with type 2 diabetes mellitus may find relief with the extended-release Glywin 30mg tablet. This sulfonylurea medication regulates blood glucose, mitigating the risk of severe diabetic complications like vision impairment and kidney dysfunction. Glywin 30mg may be used independently or in conjunction with other therapies, always taken with food and at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician, based on your response to treatment. Continuous use, even with controlled blood sugar, is crucial. Discontinuing Glywin without medical supervision can elevate blood sugar, increasing the risk of kidney damage, nerve complications, vision loss, and limb amputation. Remember, Glywin is just one component of a comprehensive diabetes management plan; a balanced diet, regular exercise, and weight management (as recommended by your doctor) are vital. Lifestyle modifications significantly impact diabetes control. Common side effects include digestive upset and hypoglycemia (low blood sugar). Learn to identify hypoglycemia symptoms – sweating, dizziness, headache, tremors – and how to manage them, including regular meals and carrying a fast-acting glucose source like juice or sweets. Alcohol consumption should be minimized as it can exacerbate hypoglycemia. Weight gain is a possible side effect. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney impairment. Inform your doctor of any pre-existing conditions, such as heart disease, thyroid disorders, or hormonal imbalances, before commencing treatment. Glywin's suitability should be assessed for pregnant or breastfeeding individuals. Regular blood sugar monitoring and periodic blood tests to assess blood cell counts and liver function will be recommended by your physician.

Primary Ingredients of Glywin 30mg Tablet MR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glywin 30mg Tablet MR

Managing type 2 diabetes

Major Benefits of Glywin 30mg Tablet MR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glywin 30mg Modified-Release tablet should be taken with a meal.

Common Side effects of Glywin 30mg Tablet MR:

  • Hypoglycemia (low blood glucose level)
  • Weight gain
  • Flatulence
  • Diarrhea
  • Headache
  • Nausea
  • Dizziness

How to use Glywin 30mg Tablet MR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glywin 30mg Modified-Release Tablet whole; avoid chewing, crushing, or breaking it. Administer with food.

How Glywin 30mg Tablet MR works:

This drug treats diabetes by stimulating the pancreas to produce more insulin, thus reducing blood glucose concentrations.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glywin 30mg MR tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glywin 30mg MR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glywin 30mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneySAFE IF PRESCRIBED

Glywin 30mg Modified-Release tablets are considered safe for use in individuals with kidney impairment; no dosage alteration is necessary. Nevertheless, this medication is prohibited for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Glywin 30mg modified-release tablets. Dosage modification of Glywin 30mg modified-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Glywin 30mg Tablet MR :

Should you forget to take your Glywin 30mg MR Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glywin 30mg Tablet MR

LabelValue
Type of Compound Improved sulfonylurea medication
Potential for Dependence None.
Type of Treatment Medication for diabetes
Mechanism of Action Secretagogues that stimulate insulin release (sulfonylureas)

FAQs on Glywin 30mg Tablet MR

Consume a Glywin 30mg Modified-Release tablet before eating, or follow your physician's precise directions. Studies suggest optimal regulation of postprandial hyperglycemia with Glywin 30mg MR when administered half an hour prior to breakfast. Therefore, for once-daily regimens, take it in the morning with breakfast and water.
Glywin 30mg Tablet MR and metformin are distinct oral medications for type 2 diabetes, differing in their mechanisms of action. Glywin 30mg Tablet MR stimulates pancreatic insulin release, whereas metformin enhances the body's utilization of existing insulin.
Concurrent use of Glywin 30mg MR tablets and metformin is permissible, but solely as directed by a physician. This combined prescription likely aims to manage elevated blood glucose levels. Concomitant administration, however, carries a risk of hypoglycemia, a risk further amplified by missed meals, increased physical activity, or insulin co-administration. Adherence to your doctor's instructions is crucial to mitigate potential adverse effects.
Glywin 30mg Tablet MR poses no kidney-related risk for individuals with normal renal function. However, prior kidney issues should be disclosed to your physician for evaluation prior to Glywin 30mg Tablet MR use. This is crucial because the medication is primarily eliminated via the kidneys, necessitating careful consideration of dosage. Patients with impaired kidney function may begin on a reduced dose.
Glywin 30mg Tablet MR
37
MRP 45
17% off